Orman, S.; Aydoğan, M.; Kınıkoğlu, O.; Yıldırım, S.; Sarıyar Busery, N.; Yıldız, H.Ş.; Türkoğlu, E.; Kaya, T.; Işık, D.; Ay Ersoy, S.;
et al. The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study. Medicina 2025, 61, 1813.
https://doi.org/10.3390/medicina61101813
AMA Style
Orman S, Aydoğan M, Kınıkoğlu O, Yıldırım S, Sarıyar Busery N, Yıldız HŞ, Türkoğlu E, Kaya T, Işık D, Ay Ersoy S,
et al. The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study. Medicina. 2025; 61(10):1813.
https://doi.org/10.3390/medicina61101813
Chicago/Turabian Style
Orman, Seval, Miray Aydoğan, Oğuzcan Kınıkoğlu, Sedat Yıldırım, Nisanur Sarıyar Busery, Hacer Şahika Yıldız, Ezgi Türkoğlu, Tuğba Kaya, Deniz Işık, Seval Ay Ersoy,
and et al. 2025. "The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study" Medicina 61, no. 10: 1813.
https://doi.org/10.3390/medicina61101813
APA Style
Orman, S., Aydoğan, M., Kınıkoğlu, O., Yıldırım, S., Sarıyar Busery, N., Yıldız, H. Ş., Türkoğlu, E., Kaya, T., Işık, D., Ay Ersoy, S., Odabaş, H., & Turan, N.
(2025). The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study. Medicina, 61(10), 1813.
https://doi.org/10.3390/medicina61101813
